Chargement en cours...
Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a disorder of the pulmonary vasculature associated with elevated pulmonary vascular resistance. Despite recent advances in the treatment of PAH, with eight approved clinical therapies and additional therapies undergoing clinical trials, PAH remains a serious...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Investigative Pathology
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3123986/ https://ncbi.nlm.nih.gov/pubmed/21549345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2011.02.032 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|